Michael Panzara
2018
In 2018, Michael Panzara earned a total compensation of $2.2M as Chief Medical Officer at Wave Life Sciences Ltd., a 108% increase compared to previous year.
Compensation breakdown
| Non-Equity Incentive Plan | $175,562 |
|---|---|
| Option Awards | $899,918 |
| Salary | $430,300 |
| Stock Awards | $700,875 |
| Other | $9,492 |
| Total | $2,216,147 |
Panzara received $899.9K in option awards, accounting for 41% of the total pay in 2018.
Panzara also received $175.6K in non-equity incentive plan, $430.3K in salary, $700.9K in stock awards and $9.5K in other compensation.
Rankings
In 2018, Michael Panzara's compensation ranked 5,191st out of 14,244 executives tracked by ExecPay. In other words, Panzara earned more than 63.6% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 5,191 out of 14,244 | 64th |
Division Manufacturing | 1,961 out of 5,758 | 66th |
Major group Chemicals And Allied Products | 717 out of 2,119 | 66th |
Industry group Drugs | 599 out of 1,808 | 67th |
Industry Pharmaceutical Preparations | 461 out of 1,382 | 67th |
Source: SEC filing on June 26, 2019.
Panzara's colleagues
We found four more compensation records of executives who worked with Michael Panzara at Wave Life Sciences Ltd. in 2018.
2018
Paul Bolno
Wave Life Sciences Ltd.
Chief Executive Officer
2018
Chandra Vargeese
Wave Life Sciences Ltd.
Senior Vice President, Drug Discovery
2018
Keith Regnante
Wave Life Sciences Ltd.
Chief Financial Officer
2018
Christopher Francis
Wave Life Sciences Ltd.